Qiantang District | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

977 results for “Qiantang District”

Trials

View all 448 →

Cohort in Qianwan New District, Ningbo

30,000 participants · First posted Apr 29, 2024

Promoting Evidence-Based Decision-Making in India: District Evaluation Study on Health

594 participants · First posted Oct 29, 2009

MNCH Programming in Southwest Uganda Maternal and Child Health In Bushenyi and Rubirizi Districts, UGANDA

10,985 participants · First posted Apr 5, 2012

Drugs

View all 19 →

Pudong New District(Insilicon Intelligent Technology Shanghai)

Qianqing Granules

Jinqi Jiangtang Capsule

Organizations

View all 77 →

North Sonoma County Hospital District

United States

WAIKATO DISTRICT HEALTH BOARD

New Zealand

Beijing Shunyi District Hospital

China

News

View all 433 →

EVA Pharma Establishes Eighth Global Office in Hangzhou's BioPharma Town to Advance Cell and Gene Therapy Innovation

Transcenta Sells Hangzhou CDMO Plant to WuXi Biologics for RMB 190 Million, Then Licenses HiCB Platform Back to the Buyer

District Court Dismisses United Therapeutics Dispute Against Liquidia in Patent Litigation

Page 1 of 98